19 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
#Management # ... Pain #Pharmacology ... Equianalgesics #Conversion ... #Doses #Dosing ... #Table #PAMI
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
of another drug ... recalls, this drug ... initiating an ARB ... #Conversion #Table ... #Dosing #Pharmacology
ACEI Antihypertensive Dose Comparison. Consider divided (BID) regimen for better pre-dose (trough) BP control for the
Antihypertensive Dose ... ACEInhibitor #ACEIs #Dosing ... #Conversion #Pharmacology ... #Hypertension #Management ... PrimaryCare #Comparison #Table
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
PDE5 inhibitors are ... e.g. at lower doses ... #pharmacology #comparison ... #medications #dosing ... #drugs #table #
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
agents since they are ... not able to effectively ... Note not listed are ... restricted due to hypercalcemia ... #Dosing #Pharmacology
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
) DOSING: TOOL ... Doses should be ... ReceptorBlocker #Pharmacology ... #Conversion #Switching ... #Equivalent #Table
Warfarin to DOAC and DOAC to Warfarin Transitions 

Here are a couple of charts to help
DOACs for easier dosing ... dosed BID, and ... <2.5, but that drug ... Anticoagulation #Pharmacology ... #Table
Pharmacologic Options for Hypercalcemia Associated with Cancer
Rehydration with NS followed by loop diuretics
 • IV normal
for Hypercalcemia ... Inhibits vitamin D conversion ... #medications #management ... #drugs #treatment ... table
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Build a regimen using ... p-Aminosalicylic acid, High-dose ... Tuberculosis #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... of patients who are ... of a given drug ... the timing and dosing ... ticagrelor #prasugrel #pharmacology